COMPANY
Glenmark Pharmaceuticals Inc., USA
Glenmark Pharmaceuticals Inc., USA: US labeler, recalling firm for Desmopressin, Octreotide, Vancomycin, as stated by public registers.
Also written as: Glenmark Pharmaceuticals Inc.,USA; GLENMARK PHARMACEUTICALS INC., USA.
US LABELER
Lists a finished product with FDA (NDC directory); can be a maker, repackager or distributor.
| Desmopressin | Desmopressin Acetate, ANDA Regulator openFDA |
|---|---|
| Octreotide | Octreotide Acetate, ANDA Regulator openFDA |
| Vancomycin | Vancomycin Hydrochloride, ANDA Regulator openFDA |
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Desmopressin | Class II recall, Terminated, 2022-07-06 Regulator openFDA |
|---|
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.